These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29925392)

  • 1. Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemia.
    Wu S; Du Y; Beckford J; Alachkar H
    J Transl Med; 2018 Jun; 16(1):170. PubMed ID: 29925392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA of vimentin expression as a valuable predictor for acute myeloid leukemia development and prognosis.
    Yi YY; Yi J; Zhu X; Zhang J; Zhou J; Tang X; Lin J; Wang P; Deng ZQ
    J Cell Physiol; 2019 Apr; 234(4):3711-3719. PubMed ID: 30152863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of pseudogene Vimentin 2p is associated with poor outcome in de novo acute myeloid leukemia.
    Zhai LL; Zhou J; Zhang J; Tang X; Zhou LY; Yin JY; Vanessa MD; Peng W; Lin J; Deng ZQ
    Cancer Biomark; 2017; 18(3):305-312. PubMed ID: 28106537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
    Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
    J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.
    Damiani D; Tiribelli M; Franzoni A; Michelutti A; Fabbro D; Cavallin M; Toffoletti E; Simeone E; Fanin R; Damante G
    Am J Hematol; 2013 Oct; 88(10):848-52. PubMed ID: 23760853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA VIM-AS1 promotes colorectal cancer progression and metastasis by inducing EMT.
    Rezanejad Bardaji H; Asadi MH; Yaghoobi MM
    Eur J Cell Biol; 2018 May; 97(4):279-288. PubMed ID: 29656793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Wang WD
    Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of vimentin-expressing gastric cancer cells in bone marrow.
    Iwatsuki M; Mimori K; Fukagawa T; Ishii H; Yokobori T; Sasako M; Baba H; Mori M
    Ann Surg Oncol; 2010 Sep; 17(9):2526-33. PubMed ID: 20358301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
    Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R
    Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance.
    Choi JE; Bae JS; Kang MJ; Chung MJ; Jang KY; Park HS; Moon WS
    Oncol Rep; 2017 Sep; 38(3):1695-1705. PubMed ID: 28677737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vimentin expression is associated with decreased survival in gastric cancer.
    Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K
    Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer.
    Polioudaki H; Agelaki S; Chiotaki R; Politaki E; Mavroudis D; Matikas A; Georgoulias V; Theodoropoulos PA
    BMC Cancer; 2015 May; 15():399. PubMed ID: 25962645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia.
    Cheng H; Huang C; Xu X; Hu X; Gong S; Tang G; Song X; Zhang W; Wang J; Chen L; Yang J
    J Transl Med; 2017 Aug; 15(1):179. PubMed ID: 28851457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Ang Q; Wang GJ; Zhu J; Wang WD
    Oncotarget; 2016 Jan; 7(3):2585-95. PubMed ID: 26506237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulated vimentin and upregulated E-cadherin in T1 stage non-small-cell lung cancer: does it suggest a mesenchymal-epithelial transition?
    Luo T; Wang L; Wu P; Gong W; Chen W; Zhao H; Zheng Z
    Neoplasma; 2017; 64(5):693-699. PubMed ID: 28592120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients.
    Tiribelli M; Raspadori D; Geromin A; Cavallin M; Sirianni S; Simeone E; Bocchia M; Fanin R; Damiani D
    Leuk Res; 2017 Jul; 58():31-38. PubMed ID: 28407515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpressed let-7a-3 is associated with poor outcome in acute myeloid leukemia.
    Li Y; Lin J; Yang J; Qian J; Qian W; Yao DM; Deng ZQ; Liu Q; Chen XX; Xie D; An C; Tang CY
    Leuk Res; 2013 Dec; 37(12):1642-7. PubMed ID: 24138945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSPG2 overexpression independently predicts poor survival in patients with acute myeloid leukemia.
    Zhou X; Liang S; Zhan Q; Yang L; Chi J; Wang L
    Cell Death Dis; 2020 Jun; 11(6):492. PubMed ID: 32606327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia.
    Candoni A; De Marchi F; Zanini F; Zannier ME; Simeone E; Toffoletti E; Chiarvesio A; Cerno M; Filì C; Patriarca F; Fanin R
    Exp Hematol; 2017 May; 49():25-33. PubMed ID: 28159598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.